CRISPR Trials Global Overview Q2 2026 from CMN Intelligence: 300+ Gene Editing Trials in the World's Only Manually Curated Global Database

Where is clinical gene editing happening, and which technologies and disease areas are driving the field?

The CMN Clinical Trials Q2 2026 Global Report draws on the CRISPR Medicine News Global Clinical Trials Database 2.0, a manually curated global database of clinical gene-editing trials. This edition covers 306 publicly disclosed trials, curated by the CMN Intelligence team as of 31 July 2026.

The United States and China lead by trial count, followed by the United Kingdom, Australia, Canada and several European countries. Beyond geography, the full report examines editing approach, cell source and delivery technologies across the global clinical gene-editing landscape.

Check out a preview here.

The full report also examines editing approach, cell source and delivery technologies across the global clinical gene-editing landscape.

Interested in accessing the full report or exploring the underlying data? Get in touch with the CMN Intelligence team.